Medtronic plc Unsponsored Brazilian Depository Receipt Repr 1/2 ShMedtronic plc Unsponsored Brazilian Depository Receipt Repr 1/2 ShMedtronic plc Unsponsored Brazilian Depository Receipt Repr 1/2 Sh

Medtronic plc Unsponsored Brazilian Depository Receipt Repr 1/2 Sh

No trades
See on Supercharts

Key facts today


Medtronic's Q2 revenue hit $8.96 billion, surpassing the $8.87 billion forecast, prompting a raised annual sales growth outlook and a nearly 5% rise in shares.
Several firms have raised their price targets for Medtronic (MDT), with Morgan Stanley at $117, RBC Capital at $118, and Goldman Sachs at $111.
Gregory L. Smith, Vice President of Medtronic PLC, filed a Form 144 with the SEC on November 19, 2025, proposing to sell 30,000 shares of restricted securities.
Analyze the impactAnalyze the impact
Market capitalization
‪657.95 B‬BRL
0.01BRL
‪26.41 B‬BRL
‪189.97 B‬BRL
Beta (1Y)
−0.40

About Medtronic plc.


CEO
Geoffrey Straub Martha
Headquarters
Galway
Founded
2014
ISIN
BRMDTCBDR004
FIGI
BBG00CRHQV45
Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the following segments: Cardiovascular Porrtfolio, Neuroscience Portfolio, Medical Surgical Portfolio, and Diabetes Operating Unit. The Cardiovascular Portfolio segment includes products for the diagnosis, treatment, and management of cardiac rhythm disorders and cardiovascular disease. The Neuroscience Portfolio is made up of cranial and spinal technologies, specialty therapies, and neuromodulation divisions. The Medical Surgical Portfolio is comprised of surgical innovations and respiratory, gastrointestinal, and renal divisions. The Diabetes Group segment offers insulin pumps, continuous glucose monitoring systems, and insulin pump consumables. The company was founded in 1949 and is headquartered in Dublin, Ireland.

Check out other big names from the same industry as MDTC34.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:

See all ideas 

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
MDT4099940
Medtronic, Inc. 4.625% 15-MAR-2044
Yield to maturity
5.71%
Maturity date
Mar 15, 2044
MDTA
Medtronic, Inc. 4.0% 01-APR-2043
Yield to maturity
5.40%
Maturity date
Apr 1, 2043
MDT4284342
Medtronic, Inc. 4.625% 15-MAR-2045
Yield to maturity
5.33%
Maturity date
Mar 15, 2045
MDT3831466
Medtronic, Inc. 4.5% 15-MAR-2042
Yield to maturity
5.31%
Maturity date
Mar 15, 2042
MDT.GM
Medtronic, Inc. 6.5% 15-MAR-2039
Yield to maturity
5.25%
Maturity date
Mar 15, 2039
MDT3673737
Covidien International Finance SA 6.55% 15-OCT-2037
Yield to maturity
5.12%
Maturity date
Oct 15, 2037
MDT.GO
Medtronic, Inc. 5.55% 15-MAR-2040
Yield to maturity
5.08%
Maturity date
Mar 15, 2040
MDT4284341
Medtronic, Inc. 4.375% 15-MAR-2035
Yield to maturity
4.63%
Maturity date
Mar 15, 2035
MDT5559704
Medtronic Global Holdings S.C.A. 4.5% 30-MAR-2033
Yield to maturity
4.51%
Maturity date
Mar 30, 2033
XS283436845
Medtronic, Inc. 4.15% 15-OCT-2053
Yield to maturity
4.50%
Maturity date
Oct 15, 2053
XS223879268
Medtronic Global Holdings S.C.A. 1.625% 15-OCT-2050
Yield to maturity
4.41%
Maturity date
Oct 15, 2050

See all MDTC34 bonds